LeadIQ logo
Learn more at LeadIQ.com

Insights

Biopharmaceutical Collaboration Recent partnership with Takeda for commercialization of rusfertide presents a collaboration opportunity to explore joint sales strategies and expand market reach.

New Product Launch Launch of IL-23 receptor antagonist peptide for moderate-to-severe plaque Psoriasis opens doors for sales teams to engage dermatologists and healthcare professionals in offering a novel treatment option.

Venture Funding Connection Investment in Agentio Inc. indicates a potential sales synergy where Protagonist Therapeutics could explore corporate partnerships or joint offerings to leverage the ad platform for tailored marketing.

Financial Backing Recent financing of $86K from Corton Capital INC showcases confidence in Protagonist Therapeutics' growth potential, providing a chance for sales teams to leverage this financial support in pitching to potential clients.

Technology Expansion Utilization of tech stack including Cloudflare, Drupal, and Backbone.js hints at a tech-savvy approach. Sales development representatives can leverage these technologies to showcase innovative solutions and attract tech-oriented clients.

Similar companies to Protagonist Therapeutics

Protagonist Therapeutics Tech Stack

Protagonist Therapeutics uses 8 technology products and services including Cloudflare CDN, Drupal, Duda, and more. Explore Protagonist Therapeutics's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Drupal
    Content Management System
  • Duda
    Content Management System
  • Backbone.js
    Javascript Frameworks
  • Microsoft
    Miscellaneous
  • MyWebsite
    Page Builders
  • New Relic
    Real User Monitoring
  • Imperva
    Security

Media & News

Protagonist Therapeutics's Email Address Formats

Protagonist Therapeutics uses at least 2 format(s):
Protagonist Therapeutics Email FormatsExamplePercentage
F.Last@ptgx-inc.comJ.Doe@ptgx-inc.com
92%
Last@ptgx-inc.comDoe@ptgx-inc.com
4%
F.Last@ptgx-inc.comJ.Doe@ptgx-inc.com
4%
F.Last@protagonist-inc.comJ.Doe@protagonist-inc.com
49%
First.Last@protagonist-inc.comJohn.Doe@protagonist-inc.com
1%
Last@protagonist-inc.comDoe@protagonist-inc.com
1%
F.Last@protagonist-inc.comJ.Doe@protagonist-inc.com
49%

Frequently Asked Questions

Where is Protagonist Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Protagonist Therapeutics's main headquarters is located at 7707 Gateway Blvd, Suite 140 Newark, California 94560 US. The company has employees across 4 continents, including North AmericaOceaniaAfrica.

What is Protagonist Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Protagonist Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Protagonist Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Protagonist Therapeutics is a publicly traded company; the company's stock symbol is PTGX.

What is Protagonist Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Protagonist Therapeutics's official website is protagonist-inc.com and has social profiles on LinkedIn.

How much revenue does Protagonist Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Protagonist Therapeutics's annual revenue reached $35M.

What is Protagonist Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Protagonist Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Protagonist Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Protagonist Therapeutics has approximately 128 employees across 4 continents, including North AmericaOceaniaAfrica. Key team members include Chief Executive Officer: D. P.Chief Executive Officer: D. R.Chief Medical Officer: A. M.. Explore Protagonist Therapeutics's employee directory with LeadIQ.

What industry does Protagonist Therapeutics belong to?

Minus sign iconPlus sign icon
Protagonist Therapeutics operates in the Biotechnology Research industry.

What technology does Protagonist Therapeutics use?

Minus sign iconPlus sign icon
Protagonist Therapeutics's tech stack includes Cloudflare CDNDrupalDudaBackbone.jsMicrosoftMyWebsiteNew RelicImperva.

What is Protagonist Therapeutics's email format?

Minus sign iconPlus sign icon
Protagonist Therapeutics's email format typically follows the pattern of . Find more Protagonist Therapeutics email formats with LeadIQ.

How much funding has Protagonist Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Protagonist Therapeutics has raised $132M in funding. The last funding round occurred on Jun 14, 2021 for $132M.

When was Protagonist Therapeutics founded?

Minus sign iconPlus sign icon
Protagonist Therapeutics was founded in 2006.
Protagonist Therapeutics

Protagonist Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications. 

Section iconCompany Overview

Headquarters
7707 Gateway Blvd, Suite 140 Newark, California 94560 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PTGX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $132M

    Protagonist Therapeutics has raised a total of $132M of funding over 10 rounds. Their latest funding round was raised on Jun 14, 2021 in the amount of $132M.

  • $10M$50M

    Protagonist Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $132M

    Protagonist Therapeutics has raised a total of $132M of funding over 10 rounds. Their latest funding round was raised on Jun 14, 2021 in the amount of $132M.

  • $10M$50M

    Protagonist Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.